OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

10 Oncology Specialists Join OncoDaily Medical Journal’s Editorial Team

Tedros Adhanom Ghebreyesus: Indonesia Contributed $30 Million to WHO

Strengthening Cancer Care Through Oncology Nursing Education and Treatment Safety

Immunotherapy Moves Into the Curative Setting for Stage III dMMR Colon Cancer – IMMONC

Carmen Uscatu: Rob Pieters Calls for Immediate Support for Marie Curie Children's Hospital

Oncology News, Insights, Stories by OncoDaily

ESMO GI 2026
Not To Miss

20 Posts Not To Miss From ESMO GI 2026, Part 1

HERIZON-GEA-01 at ESMO GI 2026
Gastrointestinal Oncology

HERIZON-GEA-01 at ESMO GI 2026: HRQoL With Zanidatamab Plus Chemotherapy in HER2-Positive mGEA

Sheila Singh
Voices

Sheila Singh: A Novel CAR‑T Strategy for Glioblastoma

What Is OncoDaily TV? One Question. Thousands of Stories - Knarik Arakelyan

Top Growing Medical Universities in Asia: 2026 Edition by BIGR

Jillian Cardarelli and Breast Cancer: Her Brave Treatment Journey and Message to Young Women

ESMO GI 2026 Merit Awards Recognize 20 Abstract Presenters

Derek Cooney: Doctor and Stage 4 Stomach Cancer Survivor Thankful for Clinical Trial at UT MD Anderson

Fundación Aladina Hosts 1st Scientific and Care Symposium on Pediatric Oncology

Beyond ctDNA: Unlocking Tissue Insights in MRD

Voices
Naoto Ueno

Naoto T Ueno: Broad Representation is the Key to Making a Difference in Oncology Community

Caroline Tonio: Critical Gaps in Oesophageal Cancer Care in Kenya and Uganda at ESMO GI 2026

21st NSW Premier’s Awards for Outstanding Cancer Research Nominations Closing Soon

Strengthening Patient Involvement in Cancer Policy in Greece - Hellenic Cancer Federation | ELLOK

State of Michigan Invests $1 Million in YesRx to Provide Free Life-Saving Cancer Medication

How Can Advocates Improve Access to Testing, Treatment, and Trials? - Global Colon Cancer Association

Miguel Bronchud: New Treatment for a Rare Cancer

FDA Approvals
FDA belzutifan plus pembro for RCC

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz (pivekimab sunirine-pvzy), the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

OncoDaily 100
100 influential survivors

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

ESSO Advanced Course on the Treatment of Peritoneal Surface Malignancy

European Society of Surgical Oncology

15 Oct
Peritoneal Surface Malignancy

ESSO Hands-On Course on the Minimally Invasive Management of Peritoneal Surface Malignancies

European Society of Surgical Oncology

15 Sep
Peritoneal Surface Malignancies

ESO-ESSO-ESTRO-ESP Multidisciplinary Course on Oncology for Medical Students

European Society for Radiotherapy and Oncology (ESTRO)

24 Aug
Oncology

ESO Ambassador Event on Neoadjuvant and Post-Neoadjuvant Treatment in Breast Cancer

European School of Oncology (ESO) College

30 Oct
Breast Cancer

Community Oncology Global Congress 2026

OncoDaily

28 Aug
Community Oncology Global Congress 2026

Immune-oncology
STAR-221 at ESMO GI 2026: Domvanalimab Plus Zimberelimab in HER2-Negative Advanced Gastric Cancer

STAR-221 at ESMO GI 2026: Domvanalimab Plus Zimberelimab in HER2-Negative Advanced Gastric Cancer

Neo-CheckRay Trial: Can Radiotherapy Turn Immune-Cold Breast Cancer Into an Immunotherapy Target?

FDA Approves Tregzi, the First Regulatory T-Cell Therapy for Allogeneic HSCT

RECLAIM Trial: Can Radiotherapy Restore Immunotherapy Sensitivity?

PD-L1 Alone Is Not Enough: Why It Fails to Predict Immunotherapy Response in NSCLC

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

FDA Approves Sacituzumab Govitecan Plus Pembrolizumab for First-Line PD-L1–Positive TNBC

Gastrointestinal-Oncology
BOT/BAL ESMO GI 2026

BOT/BAL at ESMO GI 2026: MSS Metastatic Colorectal Cancer Without Active Liver Metastases

ESMO GI 2026 Day 3 Highlights: Biomarkers, Treatment Duration, and Targeted Therapy

BREAKWATER at ESMO GI 2026: Molecular Correlates of Encorafenib Plus Cetuximab and Chemo in BRAF V600E mCRC

Zoldonrasib Plus Daraxonrasib Shows Promising Activity in KRAS G12D Metastatic Pancreatic Cancer

AGEO-NEO-MSI Trial at ESMO GI: Neoadjuvant Immunotherapy Shows High Complete Response Rates in dMMR/MSI Colorectal Cancer

HERIZON-GEA-01 at ESMO GI 2026: HRQoL With Zanidatamab Plus Chemotherapy in HER2-Positive mGEA

ATOMIC at ESMO GI 2026: Does Duration of Adjuvant Chemotherapy or Atezolizumab Matter?

Breast-Oncology
NSABP B-35

Lumpectomy Margin Width and Local Recurrence in DCIS: Findings From NSABP B-35

Can HER2DX Help Refine Neoadjuvant Treatment in Early HER2-Positive Breast Cancer?

Trastuzumab Rezetecan Extends Progression-Free Survival in Previously Treated HER2-Positive Metastatic Breast Cancer

Oral SERDs Are Redefining Endocrine Therapy in HR-Positive, HER2-Negative Breast Cancer

Ultra-High TMB May Identify a Rare Immunotherapy-Responsive Subgroup in Metastatic Breast Cancer

Enhertu Becomes the EU’s First Tumor-Agnostic HER2-Directed ADC: What the Approval Means for Solid Tumor Care

T-Bren Shows Early Activity Across HER2-Positive and HER2-Low Advanced Breast Cancer

Lung-Oncology
KRASG12C

KRASG12C Inhibitors in NSCLC Brain Metastases: Why Intracranial Control Still Requires More Than Monotherapy

New Analysis Challenges the Claim That COVID-19 mRNA Vaccines Improve Immunotherapy Outcomes

Improving Neoadjuvant and Perioperative Therapy in Resectable NSCLC: Moving Beyond a One-Size-Fits-All Approach

TP53 Gain-of-Function Mutations May Signal Early Osimertinib Resistance in EGFR-Mutant NSCLC

PD-(L)1 Rechallenge in Advanced NSCLC: A Small Signal, but Not a New Standard

Who May Be at Risk of Early Detriment With First-Line Nivolumab Plus Ipilimumab in Metastatic NSCLC?

When ADC Toxicity Is Not the Same for Everyone: A Sex-Based Signal in NSCLC

OncoDaily TV
1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

ASCO

OncoDaily Highlights from ASCO 2026 Chicago, USA

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Kefah Mokbel

Kefah Mokbel: Can Diet Influence Cancer Risk and Outcomes?

Empowering Oncologists: How to make the most of your fellowship?

Empowering Oncologists: How to make the most of your fellowship?

STAMP Inhibitors Against CML: Prof. Timothy Hughes

STAMP Inhibitors Against CML: Prof. Timothy Hughes

Oncology's Greatest Threat: A System in Crisis

Oncology’s Greatest Threat: A System in Crisis

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

Not To Miss
ESMO GI 2026

20 Posts Not To Miss From ESMO GI 2026, Part 1

Top Growing Medical Universities in Asia: 2026 Edition by BIGR

20 Posts Not To Miss From SIOP Asia Congress 2026

10 Essential Lung Cancer Posts You Can’t Miss This Week

Oncology Community Welcomes Two New FDA Approvals for Breast Cancer

15 Posts Not To Miss From ASCO Breakthrough 2026

25 Posts Not To Miss from MASCC 2026

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
MCL Mantle cell lymphoma, BTK inhibitors

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): Evolving Biology and Modern Therapeutic Paradigms

CancerWorld

Oncologists
Dilyara Kaidarova

Dilyara Kaidarova

Oncologists Location Almaty, Kazakhstan
Guillermo Chantada

Guillermo Chantada

Oncologists Location Esplugues de Llobregat, Kazakhstan
Kleida Mati

Kleida Mati

Oncologists Location Tirana, Albania
Karima Oualla

Karima Oualla

Oncologists Location Fès, Morocco
Leo Mascarenhas

Leo Mascarenhas

Oncologists Location Los Angeles, USA
Lillian Siu

Lillian Siu

Oncologists Location Toronto, Canada
Salvatore Provenzano

Salvatore Provenzano

Oncologists Location Milan, Italy
Samvel Bardakhchyan

Samvel Bardakhchyan

Oncologists Location Yerevan, Armenia

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OncoDaily Medical Journal

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Reviews

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports & Case Series

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports & Case Series